Blood Testing for Organ Injury from Covid-19
Researchers have developed a blood test that uses cell-free DNA to gauge the damage that covid-19 inflicts on cells, tissues, and organs, and could help aid in the development of new therapies.
Read MorePosted by Laurie Bonner | Feb 5, 2021 | Covid 19, Molecular Diagnostics |
Researchers have developed a blood test that uses cell-free DNA to gauge the damage that covid-19 inflicts on cells, tissues, and organs, and could help aid in the development of new therapies.
Read MorePosted by | Dec 5, 2019 | Prostate |
Unmatched resources will enable researchers to identify distinctive disease mechanisms in small patient subgroups, supporting the development of custom therapeutic approaches.
Read MorePosted by Steve Halasey | Nov 9, 2018 | Disease States, Leukemia, Lymphoma, Molecular Diagnostics |
Droplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.
Read MorePosted by Elaine Sanchez Wilson | Aug 15, 2017 | Uncategorized |
Though not universal, it is an observable phenomenon that many in vitro diagnostic manufacturers and other suppliers to the clinical laboratory community schedule their product launches to coincide with the annual meeting of the American Association for Clinical Chemistry.
Read MorePosted by Elaine Sanchez Wilson | Apr 11, 2017 | Cancer |
The company will use the award to prepare an international clinical study to evaluate its MCM5 ELISA-based urine test for prostate cancer.
Read More